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Abstract
Summary We hypothesized that the lipid profile or dyslipidemia may have an influence on the bone mineral density and bone
microstructure in an elderly Iranian population. The results of this study showed some significant associations between the serum
lipid levels and the lumbar spine and femoral areal bone mineral densities and the trabecular bone score (TBS).
Purpose Serum lipid abnormalities are possible risk factors for cardiovascular diseases and osteoporosis. Our aimwas to evaluate
the associations between the lipid profile and the areal bone mineral density (aBMD) and trabecular bone score in an elderly
Iranian population.
Methods The study subjects included 2426 elderly women and men participating in the second stage of the Bushehr Elderly
Health program, a population-based prospective cohort study. The aBMDs of the lumbar spine and femoral neck and the lumbar
spine texture were measured using dual-energy X-ray absorptiometry and the TBS algorithm, respectively. The associations
between the lipid profiles and the aBMDs and TBSs were examined using multivariable linear regression analyses stratified by
sex and adjusted for potential confounders.
Results In men, we found negative correlations between the lumbar spine aBMD and TBS and the total cholesterol (TC), high-
density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels (TC: p < 0.001 and p < 0.006,
HDL-C: p = 0.002 and p = 0.004, and LDL-C: p < 0.001 and p < 0.009, respectively). However, only the HDL-C level was
negatively associated with the aBMD in women (p = 0.016). A positive and statistically significant correlation was found
between the serum triglyceride (TG) level and the aBMD in the women (p < 0.001). The TG level and the TBS were not
statistically significantly correlated in either sex, and the TBS was not correlated with any of the lipid values in women.
Conclusion The results of this study showed some significant but generally weak associations between the lipid profile and the
aBMD. The associations that were significant for both the men and the women included positive associations between the TG
level and the femoral neck aBMD, as well as the HDL-C level and the femoral neck and lumbar spine aBMDs.
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Introduction
As the population ages, we are faced with many more age-
related degenerative diseases than ever before, including os-
teoporosis. Although osteoporosis is more common in post-
menopausal women, many elderly men suffer from this con-
dition as well, and they are often left undiagnosed and untreat-
ed [1]. Osteoporosis-induced fractures and complications im-
pose great short-term and long-term burdens [2]. The preva-
lences of osteoporosis and low bone mass in Iran have been
reported to be as high as 19% and 40%, respectively, for
women and 12% and 33%, respectively, for men, according
to one meta-analysis study [3].
Osteoporosis and cardiovascular disease are two major
public health problems, especially among the elderly, and they
are strongly linked according to previous epidemiological
studies [4, 5]. One systematic review revealed that individuals
with subclinical cardiovascular disease are 2.3 to 3.0 times
more prone to bone loss and fragility fractures when compared
with individuals without this condition. It also showed that
those individuals with low bone mass are more prone to car-
diovascular events and that they have higher mortality rates
[6]. Moreover, cardiovascular diseases and osteoporosis share
certain risk factors, such as age, premature menopause, genet-
ics, a sedentary lifestyle, smoking, a vitamin D deficiency, and
diabetes; however, other factors, such as gender and obesity,
can have different effects upon these two conditions [7, 8].
Some pathophysiological explanations and common genetic
backgrounds could contribute to these associations, including
those biological factors contributing to vascular atherosclero-
sis and bone remodeling, such as oxidized lipids, sclerostin,
osteoprotegerin, and fibroblast growth factor-23 [7, 9–12].
The estrogen deficiency and inflammatory cytokines exhibit-
ed during the postmenopausal period can affect osteoclast
activity, which can lead to bone loss; however, they also seem
to be associated with atherogenesis [13, 14]. Conversely, the
medications used for the treatment of osteoporosis and dyslip-
idemia, such as bisphosphonates and statins, seem to affect
both bone tissue and atherosclerotic plaques [15, 16]. A
population-based study in Spain revealed a higher femoral
neck bone mineral density (BMD) in women taking lipophilic
statins; however, different trends have been observed among
different sexes and different types of statins [17].
Dyslipidemia is a major risk factor for cardiovascular dis-
ease, and some studies have suggested that it is associated
with a low bone mass, but there is great inconsistency among
the reported findings [4, 7, 18–25].
Although the areal BMD (aBMD) is considered for the
diagnosis of osteoporosis, most fragility fractures occur in
osteopenic or normal bone. Other bone features that determine
the bone quality, such as the microarchitecture, mineralization
level, bone remodeling rate, and microdamage accumulation,
also contribute to fragility fractures. The trabecular bone score
(TBS) was derived from lumbar spine dual-energy X-ray ab-
sorptiometry (DXA) images measured using TBS iNsight
software (version 2.2; Medimaps Group, Plan-les-Ouates,
Switzerland). It was developed to assess the image texture as
a novel index for the lumbar spine trabecular microstructure
state, and it was introduced as a complement to the aBMD and
partially independent from the aBMD for assessing the frac-
ture risk [26–28]. The TBS change predictors differ from
those of the aBMD in elderly men; for example, weight loss
is associated with a decreased aBMD, while weight gain and
obesity are associated with a decreased TBS [29].
Most previous studies about the relationships between the
lipid parameters and the aBMD have been performed using
smaller samples, and they focused mainly on postmenopausal
women with regard to a few confounding factors. Therefore,
the aim of this study was to evaluate whether higher lipid
levels are associated with a lower aBMD and a lower TBS
in an elderly Iranian population. To the best of our knowledge,
this is the first study to examine the correlations between the
lipid profile and the TBS and aBMD in a large-scale popula-
tion of elderly women and men while considering several
potential confounders.
Methods
Subjects
The present study included 1260 women and 1166 men
older than 60 years (age means of 69.16 (± 6.35) years old
and 69.54 (± 6.44) years old, respectively) participating in
the second stage of the Bushehr Elderly Health (BEH)
program. The rationale and design of the original study
has been described elsewhere [30, 31]. In summary, the
BEH program is a population-based prospective cohort
study that has been conducted in Bushehr, a southern
province of Iran, since March of 2013. The main aim of
this study was to investigate the prevalence of non-
communicable diseases and the associated risk factors.
The inclusion criteria were an age ≥ 60 years old and ad-
equate physical and mental abilities to participate in the
evaluation program. In the second stage, which began in
October of 2015, the study was designed to estimate the
prevalences of musculoskeletal disorders, including oste-
oporosis (among other non-communicable diseases) and
their risk factors and the outcomes of these disorders,
such as falling, fractures, poor mobility, and functional
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dependence, during the follow-ups among the elderly par-
ticipants. The data collection was designed to occur at
2.5-year intervals.
aBMD and trabecular structure measurements
All of the subjects underwent lumber spine (L1–L4) and
proximal hip aBMD measurements using DXA (Discovery
Wi Bone Densitometer; Hologic, Bedford, MA, USA), fol-
lowing the International Society for Clinical Densitometry
guidelines [32]. We used TBS iNsight software, which in-
directly measures the lumbar spine trabecular microstruc-
ture based on a textural analysis of the DXA images of the
lumbar spine region [33, 34].
Lipid profile measurements
The lipid profile, including the total cholesterol (TC), triglyc-
eride (TG), low-density lipoprotein cholesterol (LDL-C), and
high-density lipoprotein cholesterol (HDL-C) levels, was
measured using the enzymatic photometric method with a
commercial kit (Pars Azmun Co., Karaj, Iran) with total pre-
cision errors (expressed as the coefficient of variation) of
1.6%, 1.9%, 1.5%, and 1.8%, respectively.
Statistical analysis
We described the data using frequencies and percentages for
the categorical variables and means (± standard deviations) for
the continuous variables. Where applicable, we used the two-
Table 1 Descriptive
characteristics of the study
population
Women (n = 1260) Men (n = 1166)
Age (years) 69.2 (6.4) 69.5 (6.4)
Body characteristics Weight (Kg) * 66.6 (13.1) 72.3 (12.4)
Height (cm)* 152.2 (6.1) 165.9 (6.3)
BMI (Kg/cm2)* 28.7 (5.3) 26.2 (4.0)
Waist circumference (cm)* 100.2 (12.5) 97.1 (11.2)
Hip circumference (cm)* 105.6 (11.2) 99.3 (7.7)
Years since menopause 21.3(7.9) –
Lipid profile TG (mg/dl)* 141.2 (72.0) 130.3 (68.3)
TC (mg/dl)* 190.4 (45.5) 173.3 (40.8)
HDL-C (mg/dl)* 48.6 (11.5) 43.1 (10.1)
LDL-C (mg/dl)* 113.9 (39.7) 104.6 (34.8)
LDL-C to HDL-C ratio 2.5 (1.0) 2.5 (0.9)
TC to HDL-C ratio 4.1 (1.3) 4.2 (1.2)
Bone status* TBS (L1-L4) 1.241 (0.088) 1.354 (0.092)
Lumbar spine aBMD (g/cm2) 0.811 (0.143) 0.990 (0.172)
Femoral neck aBMD (g/cm2) 0.588 (0.111) 0.731 (0.1340
Total hip aBMD (g/cm2) 0.756 (0.128) 0.944 (0.143)
Osteoporosis (T score − 2.5 or less) 524(44.6%) 176(16.1%)
Osteopenia (T score between − 1 and − 2.5) 522(44.4%) 458(42.0%)
Normal (T score − 1 or more) 129(11.0%) 457(41.9%)
Biochemistry Calcium* (mg/dl) 9.38(0.52) 9.30(0.51)
Phosphorus* (mg/dl) 4.17(0.51) 3.88(0.56)
Alkaline phosphatase* (IU/L) 231.87(78.11) 208.22(71.23)
Education level* University 29 (2.31%) 164 (14.07%)
High school 111 (8.82%) 249 (21.36%)
Secondary school 135 (10.73%) 223 (19.13%)
Primary school 396 (31.48%) 316 (27.10%)
No education 587 (46.66%) 214 (18.35%)
Smoking (yes)* 176(14.1%) 242(20.8)
Physical activity (yes) 287(23.0%) 280(24.3%)
Data are presented as Mean (SD) for continuous variables and number (percent) for categorical variables. TG,
triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol; aBMD, areal bone mineral density; TBS, trabecular bone score; *p value < 0.001
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group independent t test for the continuous variables and the
Pearson chi-squared test for the categorical variables in order
to compare the variables between the women and the men.We
examined the associations between the lipid profiles and the
aBMD and TBS of the lumbar spine (L1–L4) and the femoral
neck aBMD using univariable and multivariable linear regres-
sion analyses. We stratified the participants by sex, and we
adjusted the analysis for the other potential confounders. The
models used for the regression analysis included the unadjust-
ed values, the reduced model adjusted for the main con-
founders (age, body mass index (BMI), educational level,
and smoking status), and the full model adjusted for the other
potential confounders (waist circumference, years since men-
opause (for the women), physical activity, calcium, phospho-
rus, and alkaline phosphatase). We also calculated partial eta-
squared values as a measure of the effect size.
We divided the participants according to the tertiles of the
TBS and the lumbar spine and femoral neck aBMDs, and we
considered the new variable to be our outcome (three levels).
Due to the multinomial categorized types of TBSs and
aBMDs, we used a multinomial logistic regression (the par-
ticipants in the first tertile were considered to be the reference
group). For the continuous variables in this model, we had the
relative risk ratio (RRR) for a one-unit increase in the contin-
uous variable being equal to the exponentiation (beta). We
selected each variable to include in the model as a potential
confounder if the corresponding p value was less than 0.2 in
the univariate analysis. Those p values of less than 0.05 were
considered to be statistically significant.
The statistical analysis was performed using 2013 Stata
Statistical Software (Release 13; StataCorp LLC, College
Station, TX, USA).
Results
The basic characteristics of the participants, including the age,
body composition, educational level, bone status, and lipid
profile, are presented in Table 1.
The men had statistically significantly lower BMI, TG,
TC, HDL-C, and LDL-C levels when compared with the
women (p < 0.001). However, the LDL-C to HDL-C ratio
and the cholesterol to HDL-C ratio tended to be higher in
the men, but not statistically significantly (p = 0.065 and
p = 0.082, respectively).
Fig. 1 Scatter plots and least-square fitted lines of lipid profile and lumbar spine areal bone mineral density; B: Standardized beta.
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The mean lumbar aBMD was lower in the women when
compared with the men (0.823 (± 0.149) g/cm2 vs. 1.010 (±
0.180) g/cm2, p < 0.001). We found similar trends for the fem-
oral neck and total hip aBMDs as well as the TBS (Table 1).
The associations between the lipid profile and the lumbar
spine aBMD and TBS are illustrated in Figs. 1 and 2. The
results of the unadjusted linear regression, the results after
adjusting for the age, BMI, educational level, and smoking
status in the reduced model, and the results after adjusting
for the age, BMI, waist circumference, years since menopause
(for the women), physical activity, educational level, smoking
status, calcium, phosphorus, and alkaline phosphatase in the
full model, stratified by sex, are presented in Table 2. The eta-
squared values are presented as measures of the effect size as
well.
In the men, we found negative correlations between the
lumbar spine aBMD and the TBS but not the femoral neck
aBMD and the TC level in the full model (β = − 0.0996 and
p < 0.001, β = − 0.0784 and p = 0.006, and β = − 0.0477 and
p = 0.087, respectively). The lumbar spine aBMD, TBS, and
femoral neck aBMD were all inversely correlated with the
HDL-C and LDL-C values in the men (HDL-C: β = −
0.0892 and p = 0.002, β = − 0.0832 and p = 0.004, and β = −
0.0644 and p = 0.021, respectively; LDL-C: β = − 0.0987 and
p < 0.001, β = − 0.0742 and p = 0.009, and β = − 0.0644 and
p = 0.020, respectively). However, the strengths of the associ-
ations, as indicated by the eta-squared, were generally weak
and less than 1%. In the men, the correlation between the
lumbar spine aBMD and the TG level was not statistically
significant after the adjustment in both models; however, the
femoral neck aBMD was correlated with the TG level (β =
0.0727, p = 0.010). No correlations were found between the
TBS and the TG level in either the men or the women.
In the women, we found a negative correlation between the
lumbar spine and the femoral neck aBMDs and the HDL-C
level in the full model (β = − 0.0560, p = 0.016 and β = −
0.0608, p = 0.016, respectively) with an eta-squared of less
than 1%. However, neither the lumbar spine and femoral neck
aBMDs nor the TBS was statistically significantly correlated
with the TC or the LDL-C values in the women (Table 2).
However, the serum TG level had a positive and statistically
significant correlations with the lumbar spine and femoral
neck aBMDs in the women (β = 0.1050, p < 0.001 and β =
0.0652, p = 0.009, respectively) with eta-squared values of
1.51% and 0.57%, respectively. The TBS was not correlated
with any of the lipids measured in the women.
Fig. 2 Scatter plots and least-square fitted lines of lipid profile and trabecular bone score; B: Standardized beta.
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The LDL-C to HDL-C ratio was not statistically signifi-
cantly correlated with the aBMDs or TBS in either sex.
However, the TC to HDL-C ratio was statistically significant-
ly correlated with the lumbar spine and femoral neck aBMDs
in the women (β = 0.0553, p = 0.023 and β = 0.0632, p =
0.010, respectively).
The associations between the tertiles of the aBMDs and
TBS and the lipid profile are presented in Tables 3, 4, and 5.
After adjusting for the confounders, the men within the
highest third of the lumbar aBMD had significantly lower
TC, HDL-C, and LDL-C levels when compared with those
within the lowest third (RRR = 0.9941 and p = 0.003, RRR =
0.9786 and p = 0.006, and RRR = 0.9926 and p = 0.001, re-
spectively). The men within the third TBS tertile had statisti-
cally significantly lower TC and LDL-C levels (RRR =
0.9950, p = 0.009 and RRR = 0.9939, p = 0.006, respective-
ly). Moreover, the men in the third femoral neck aBMD tertile
had a significantly higher TG levels when compared with
those in the first tertile (RRR = 1.0031, p = 0.008).
However, the women within the highest tertiles of both the
lumbar aBMD and femoral neck aBMD had significantly
lower HDL-C levels (RRR = 0.9812, p = 0.012 and RRR =
0.9753, p = 0.001, respectively) and higher TG levels
(RRR = 1.0040, p = 0.001 and RRR = 1.0031, p = 0.008, re-
spectively) relative to those within the lowest third. The
TBS tertiles were not associated with any of the measured
lipids in the women (Table 5).
Discussion
In this study, we evaluated the associations between the
aBMD and TBS (surrogates of the bone state) and the lipid
profile in an elderly Iranian population, and we found some
relationships (mainly in the men); however, an interpretation
is difficult due to the many variables that can potentially affect
the aBMD and TBS measurements.
Most studies about the correlations between the BMD and
lipid profile are performed among women, especially post-
menopausal women.Moreover, the different studies have con-
flicting results, and some of them are partially consistent with
our findings. For example, some of the studies of Iranian [19]
Table 3 Association between lipid profile and femoral neck aBMD
Lipids Femoral neck aBMD tertiles
Women Men
T1 T2 T3 T1 T2 T3
TG Model 1 1 1.0018
(0.9997, 1.0039)
1.0040
(1.0019, 1.0060)**
1 1.0041
(1.0018, 1.0065)*
1.0056
(1.0033, 1.0080)**
Model 2 1 1.0008
(0.9987, 1.0030)
1.0030
(1.0008, 1.0052)*
1 1.0023
(0.9999, 1.0046)
1.0031
(1.0007, 1.0055)*
Model 3 1 1.0011
(0.9989, 1.0033)
1.0031
(1.0008, 1.0054)*
1 1.0022
(0.9997, 1.0046
1.0030
(1.0005, 1.0054)*
TC Model 1 1 0.9994
(0.9964, 1.0024)
1.0010
(0.9980, 1.0040)
1 1.0014
(0.9980, 1.0049)
0.9998
(0.9963, 1.0032)
Model 2 1 0.9994
(0.9963, 1.0026)
1.0015
(0.9981, 1.0048)
1 1.0005
(0.9969, 1.0040)
0.9989
(0.9952, 1.0027)
Model 3 1 0.9996
(0.9964, 1.0029)
1.0011
(0.9976, 1.0046)
1 0.9997
(0.9960, 1.0034)
0.9981
(0.9942, 1.0020)
HDL-C Model 1 1 0.9890
(0.9775, 1.0007)
0.9808
(0.9692, 0.9926)*
1 0.9825
(0.9689, 0.9963)*
0.9821
(0.9685, 0.9960)*
Model 2 1 0.9884
(0.9761, 1.0009)
0.9794
(0.9662, 0.9928)*
1 0.9890
(0.9749, 1.0030)
0.9923
(0.9772, 1.0076)
Model 3 1 0.9870
(0.9741, 1.0001)
0.9753
(0.9613, 0.9896)*
1 0.9901
(0.9756, 1.0048)
0.9938
(0.9783, 1.0095)
LDL-C Model 1 1 0.9989
(0.9955, 1.0024)
0.9999
(0.9965, 1.0033)
1 1.0009
(0.9968, 1.0049)
0.9973
(0.9932, 1.0014)
Model 2 1 0.9995
(0.9958, 1.0031)
1.0009
(0.9971, 1.0048)
1 1.0002
(0.9960, 1.0044)
0.9970
(0.9926, 1.0015)
Model 3 1 0.9996
(0.9959, 1.0033)
1.0006
(0.9967, 1.0046)
1 0.9991
(0.9948, 1.0035)
0.9959
(0.9914, 1.0004)
Relative risk ratios with 95% confidence intervals are presented. Model 1: unadjusted; Model 2: adjusted for age, BMI, education level, and smoking;
Model 3: adjusted for age, BMI, waist circumference, years since menopause (for women), physical activity, education level, smoking, calcium,
phosphorus, and alkaline phosphatase; aBMD, areal bone mineral density; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol. Femoral neck aBMD tertiles: formen: T1 less than 0.664, T2 between 0.664 and 0.777, T3more
than 0.777; for women T1 less than 0.540, T2 between 0.540 and 0.633, T3 more than 0.633; *p value < 0.05, **p value < 0.001
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and Korean [18] postmenopausal women found no correla-
tions between the serum lipids and the aBMD. Regarding
the associations between the TC and LDL-C levels and the
aBMD, some studies revealed no associations among the
women [4, 21–23, 35] and the men [4, 24, 25]; however, some
showed negative correlations with the femoral aBMD but not
with the lumbar spine aBMD [25] in the women. One study
reported that only the TC level could be a significant indepen-
dent risk factor for osteoporosis in postmenopausal women
[20]. When considering the association between the HDL-C
level and the aBMD, some studies have proposed that the
HDL-C level is a risk factor in women [21, 35] and in men
[21, 24]. However, some have suggested that it is protective in
women [4, 25] (just because it has a favorable effect on the
cardiovascular risk), but others have reported no association in
men [25]. With regard to the correlation between the TG level
and the aBMD, some studies have reported positive correla-
tions in women and in men [21, 24], while others have found
no association in women [20, 35]. Only a few studies have
evaluated the correlations between the aBMD and the LDL-C
toHDL-C ratio and the TC toHDL-C ratio. One study showed
a negative relationship between the HDL-C to LDL-C ratio
and the femoral aBMD but not the lumbar aBMD in both
women andmen, which persisted in the women after adjusting
for adiposity [24].
There are some pathophysiological explanations for the
association that has been observed between dyslipidemia
and bone loss. Multipotent mesenchymal stem cells in the
bone marrow, as progenitor cells, can differentiate into osteo-
blasts, chondrocytes, and adipocytes, contributing to both
bone and fat tissues [36]. It seems that lipid and bone metab-
olism is correlated and mutually regulated. However, dyslip-
idemia and lipid metabolism disorders can interact with bone
and lead to bone loss. They can also enhance endothelin pro-
duction, leading to an increase in the risk of thrombus forma-
tion. The associations between bone and lipid, from a molec-
ular and biological point of view, are well described in a re-
view article by Tian and Yu [36]. The peroxisome proliferator-
activated receptor γ (PPARγ), which is a mediator of lipid
metabolism, is activated by lipid metabolites. PPARγ, as well
as lipid oxidation products, can inhibit osteoblast differentia-
tion. Moreover, they can direct the progenitor mesenchymal
stem cells toward adipogenesis rather than osteogenic differ-
entiation [37, 38]. These mechanisms can enhance bone loss.
Additionally, in studies using metabolomic approaches, lipids
and fatty acids have been shown to discriminate between os-
teoporosis and normal conditions, determining the role of lipid
metabolism as a related metabolic pathway. For example, one
study in China on the association between the metabolome
and the aBMD using gas chromatography–mass spectrometry
determined the five free fatty acids that had the greatest po-
tential to be used as biomarkers, and the authors suggested that
a lipid profile could be useful for the prediction of osteoporot-
ic bone loss [39]. Metabolomic studies performed using the
Table 2 Correlation between lipid profile and aBMD and TBS
Variables Femoral neck aBMD Lumbar spine (L1-L4) aBMD Lumbar spine (L1-L4) TBS
Women Men Women Men Women Men
Beta Eta2 Beta Eta2 beta Eta2 beta Eta2 beta Eta2 beta Eta2
TG Model 1 0.1071** 0.1425** 0.1523** 0.0961* 0.0075 − 0.0112
Model 2 0.0625* 0.52% 0.0737* 0.60% 0.1039** 1.49% 0.0365 0.14% 0.0243 0.07% 0.0164 0.03%
Model 3 0.0652* 0.57% 0.0727* 0.58% 0.1050** 1.51% 0.0255 0.07% 0.0406 0.19% 0.0192 0.04%
TC Model 1 0.0118 − 0.0210 0.0165 − 0.0716* 0.0105 − 0.0712*
Model 2 0.0207 0.06% − 0.0343 0.14% 0.0158 0.03% − 0.0863* 0.84% 0.0176 0.04% − 0.0657* 0.47%
Model 3 0.0201 0.06% − 0.0477 0.26% 0.0160 0.03% − 0.0996** 1.10% 0.0107 0.01% − 0.0784* 0.67%
HDL-C (mg/dl) Model 1 − 0.0714* − 0.1073** − 0.0633* − 0.1253** − 0.0036 − 0.0466
Model 2 − 0.0553* 0.40% − 0.0665* 0.50% − 0.0552* 0.42% − 0.0889* 0.87% − 0.0187 0.04% − 0.0765* 0.63%
Model 3 − 0.0608* 0.48% − 0.0644* 0.47% − 0.0560* 0.48% − 0.0892* 0.88% − 0.0448 0.22% − 0.0832* 0.75%
LDL-C (mg/dl) Model 1 − 0.0088 − 0.0496 − 0.0185 − 0.0846* 0.0115 − 0.0654*
Model 2 0.0124 0.02% − 0.0494 0.28% − 0.0053 0.00% − 0.0891* 0.90% 0.0184 0.04% − 0.0615* 0.41%
Model 3 0.0114 0.02% − 0.0644* 0.48% − 0.0047 0.00% − 0.0987** 1.09% 0.0112 0.01% − 0.0742* 0.60%
LDL-C to
HDL-C ratio
Model 1 0.0349 0.0185 0.0114 0.0026 0.0108 − 0.0241
Model 2 0.0461 0.28% 0.0000 0.00% 0.0226 0.07% − 0.0214 0.05% 0.0239 0.07% − 0.0038 0.00%
Model 3 0.0451 0.28% − 0.0126 0.02% 0.0231 0.08% − 0.0284 0.09% 0.0290 0.10% − 0.0100 0.01%
TC to
HDL-C ratio
Model 1 0.0663* 0.0788* 0.0553 0.0527 0.0144 − 0.0085
Model 2 0.0619* 0.51% 0.0393 0.17% 0.0546* 0.42% 0.0128 0.02% 0.0255 0.07% 0.0182 0.04%
Model 3 0.0632 0.55% 0.0293 0.10% 0.0553* 0.43% 0.0045 0.00% 0.0366 0.16% 0.0145 0.02%
Standardized beta and squared eta are presented. Model 1: unadjusted; Model 2: adjusted for age, BMI, education level, and smoking;Model 3: adjusted
for age, BMI, waist circumference, years since menopause (for women), physical activity, education Level, smoking, calcium, phosphorus, and alkaline
phosphatase; aBMD, areal bone mineral density; TBS, trabecular bone score; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol. *p value < 0.05, **p value < 0.001
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plasma of ovariectomized rats have revealed increases in the
LDL-C, very low-density lipoprotein cholesterol (vLDL-C),
and lipid levels [40]. Moreover, we found a positive correla-
tion between the TG level and both the spinal and femoral
neck aBMDs in women, but the correlation was lost with the
spinal aBMD in the men after adjusting for the age and BMI.
This trend in men has been observed in other studies as well
[25]. In one UK study, the association between the TG level
and the aBMD was no more significant if the body fat per-
centage was substituted for the waist–hip ratio in the regres-
sion model [24]. This can reveal the positive association be-
tween the TG level and the aBMD, and if observed, it can be
explained by adiposity.
The correlations (either the inverse correlations in men
or the lack of correlation in women) observed between the
TC and LDL-C levels and the bone status were consistent
for the spinal aBMD and the TBS, indicating the similar
effects of these lipids on the bone density and quality. The
HDL-C was negatively correlated with the spinal and
femoral neck aBMDs and the TBS in the men; however,
it was negatively correlated with the spinal and femoral
neck aBMDs but not the TBS in the women. Moreover,
the TG level seemed to have a positive effect on the
aBMD but not on the TBS in the women. Therefore, we
did not find any positive effects of the TG level on the
bone quality. Consistently, the LDL-C to HDL-C ratio
and the TC to HDL-C ratio, which are indices of ischemic
heart disease [41] and better for determining the cardio-
vascular risk, were not associated with either the aBMD or
the TBS in the men. One study of Turkish postmenopausal
women revealed no correlations between the serum lipids
and the aBMD, other than weak associations between the
TC and LDL-C levels and the aBMD in the forearm re-
gion; however, the results showed the impact of the serum
lipids on vertebral fractures [23]. This suggests that the
bone quality, rather than the mere density, may be influ-
enced by dyslipidemia, indicating the importance of eval-
uating the TBS as well as the aBMD. In addition, it has
Table 4 Association between lipid profile and lumbar spine aBMD
Lipids Lumbar spine aBMD tertiles
Women Men
T1 T2 T3 T1 T2 T3
TG Model 1 1 1.0020
(0.9998–1.0042)
1.004832
(1.0027–1.0069)**
1 1.0038
(1.0016–1.0061)*
1.0044
(1.0021–1.0066)**
Model 2 1 1.0011
(0.9989–1.0033)
1.0039
(1.0017–1.0061)*
1 1.0025
(1.0002–1.0048)*
1.0024
(1.0001–1.0048)*
Model 3 1 1.0010
(0.9988–1.0033)
1.0040
(1.0018–1.0063)*
1 1.0019
(0.9995–1.0042)
1.0018
(0.9995–1.0042)
TC Model 1 1 1.0023
(0.9993–1.0053)
1.0017
(0.9986–1.0047)
1 1.0012
(0.9978–1.0047)
0.9965
(0.9930–0.9999)*
Model 2 1 1.0024
(0.9992–1.0057)
1.0021
(0.9987–1.0056)
1 1.0002
(0.9967–1.0038
0.9953
(0.9916–0.9990)*
Model 3 1 1.0030
(0.9996–1.0064)
1.0024
(0.9988–1.0060)
1 0.9993
(0.9956–1.0030)
0.9941
(0.9903–0.9980)*
HDL-C Model 1 1 0.9911
(0.9794–1.0028)
0.9858
(0.9741–0.9977)*
1 0.9891
(0.9755–1.0028)
0.9728
(0.9590–0.9868)**
Model 2 1 0.9900
(0.9775–1.0027)
0.9831
(0.9694–0.9969)*
1 0.9937
(0.9796–1.0080)
0.9795
(0.9648–0.9944)*
Model 3 1 0.9896
(0.9765–1.0029)
0.9812
(0.9669–0.9958)*
1 0.9946
(0.9801–1.0092)
0.9786
(0.9635–.9940)*
LDL-C Model 1 1 1.0026
(0.9992–1.0061)
1.0003
(0.9968–1.0038)
1 1.0001
(0.9961–1.0042)
0.9945
(0.9904–0.9986)*
Model 2 1 1.0030
(0.9993–1.0067)
1.0014
(0.9974–1.0054)
1 0.9991
(0.9950–1.0034)
0.9937
(0.9894–0.9980)*
Model 3 1 1.0036
(0.9998–1.0075)
1.0017
(0.9976–1.0058)
1 0.9982
(0.9939–1.0025)
0.9926
(0.9882–0.9971)*
Relative risk ratios with 95% confidence intervals are presented. Model 1: unadjusted; Model 2: adjusted for age, BMI, education level, and smoking;
Model 3: adjusted for age, BMI, waist circumference, years since menopause (for women), physical activity, education level, smoking, calcium,
phosphorus, and alkaline phosphatase; aBMD, areal bone mineral density; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein
cholesterol; LDL-C, low-density lipoprotein cholesterol. Lumbar aBMD tertile: for men: T1 less than 0.910, T2 between 0.910 and 1.056, T3 more than
1.0560; for women T1 less than 0.784, T2 between 0.784 and 0.865, T3 more than 0.865; *p value < 0.05, **p value < 0.001
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been suggested that obesity has opposing effects on the
bone health, and a higher BMI may be associated with a
higher aBMD, while it may also be associated with poor
metabolic health and bone strength. This effect on bone
health has been shown to vary among different age and
gender categories [42]. Therefore, obese patients and un-
derweight patients could be at risk for fragility fractures,
both requiring attention. Another study revealed that
weight loss is associated with decreased lumbar spine
and total hip aBMDs but an increased TBS when assessed
via densitometry [29]. Thus, the factors predicting TBS
changes may differ from those predicting aBMD changes.
However, the longitudinal findings in elderly men who
were losing weight have suggested that the association
between the fat mass and bone mass is not limited to its
loading effect, that fat and bone also have a metabolic
relationship, and that the role of fat in bone metabolism
increases with age [43]. In order to have healthy bones, it
is important for elderly men to maintain their body weight
and fat mass, and this highlights the importance of the
prevention of osteosarcopenia in the elderly.
This study did have a number of limitations. For example,
we did not have access to the supplement intakes, vitamin D
levels, or fracture data of the participants. However, the main
strength of this study lies in the fact that we included men as
well as women through a large sample size population-based
study. Additionally, for the first time, as far as we know, we
evaluated the correlations between the lipid profile and the
TBS as a novel index of bone quality. We also included the
LDL-C to HDL-C ratio and the TC to HDL-C ratio as indices
of the cardiovascular risk in our analyses. However, no causal
relationship can be concluded due to the study’s cross-
sectional design. Moreover, the participants may not be repre-
sentative of the entire Iranian population. We adjusted the
analysis for the age, BMI, waist circumference, years since
menopause (for the women), physical activity, educational
level, and smoking status because these are the major factors
affecting the bone.
Table 5 Association between lipid profile and TBS
Lipids TBS tertiles
Women Men
T1 T2 T3 T1 T2 T3
TG Model 1 1 1.0007
(0.9988–1.0026)
1.0003
(0.9983–1.0022)
1 1.0016
(0.9995–1.0036)
0.9999
(0.9978–1.0020)
Model 2 1 1.0013
(0.99933–1.0034)
1.0008
(0.9988–1.0030)
1 1.0030
(1.0008–1.0052)*
1.0003
(0.9980–1.0026)
Model 3 1 1.0016
(0.9995–1.0037)
1.0017
(0.9995–1.0039)
1 1.0031
(1.0008–1.0053)*
1.0006
(0.9982–1.0029)
TC Model 1 1 1.0014
(0.9984–1.0044)
1.0007
(0.9976–1.0037)
1 0.9994
(0.9960–1.0029)
0.9958
(0.9923–0.9992)*
Model 2 1 1.0017
(0.9986–1.0048)
1.0013
(0.9981–1.0045)
1 0.9997
(0.9961–1.0032)
0.9955
(0.9919–0.9992)*
Model 3 1 1.0015
(0.9983–1.0047)
1.0007
(0.9974–1.0040)
1 0.9991
(0.9955–1.0027)
0.9950
(0.9913–0.9988)*
HDL-C Model 1 1 0.9954
(0.9836–1.0073)
0.9993
(0.9875–1.0112)
1 0.9939
(0.9801–1.0079)
0.9935
(0.9798–1.0074)
Model 2 1 0.9941
(0.9818–1.0067)
0.9967
(0.9840–1.0095)
1 0.9858
(0.9716–1.0002)
0.9885
(0.9740–1.0033)
Model 3 1 0.9908
(0.9778–1.0040)
0.9882
(0.9749–1.0018)
1 0.9854
(0.9710–1.0000)
0.9882
(0.9733–1.0032)
LDL-C Model 1 1 1.0017
(0.9983–1.0052)
1.0006
(0.9971–1.0041)
1 0.9985
(0.9945–1.0026)
0.9948
(0.9908–0.9989)*
Model 2 1 1.0019
(0.9983–1.0054)
1.0013
(0.9976–1.0049)
1 0.9985
(0.9944–1.0027)
0.9946
(0.9904–0.9989)*
Model 3 1 1.0016
(0.9980–1.0052)
1.0006
(0.9969–1.0044)
1 0.9978
(0.9936–1.0021)
0.9939
(0.9895–0.9982)*
Relative risk ratios with 95% confidence intervals are presented. Model 1: unadjusted; Model 2: adjusted for age, BMI, education level, and smoking;
Model 3: adjusted for age, BMI, waist circumference, years since menopause (for women), physical activity, education level, smoking, calcium,
phosphorus, and alkaline phosphatase; TBS, trabecular bone score; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol;
LDL-C, low-density lipoprotein cholesterol. TBS tertiles: for men: T1 less than 1.324, T2 between 1.324 and 1.395, T3 more than 1.395; for women T1
less than 1.205, T2 between 1.205 and 1.280 and T3 more than 1.280; *p value < 0.05, **p value < 0.001
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Conclusion
This study showed that the elderly men with higher TC, HDL-
C, and LDL-C levels had lower lumbar spine aBMDs and
worse TBSs. However, the elderly women with higher
HDL-C (but not TC and LDL-C) levels exhibited lower fem-
oral neck and lumbar spine aBMDs but not TBSs. Moreover,
the elderly women with higher TG levels had higher lumbar
spine and femoral neck aBMDs, while the elderly men with
higher TG levels had higher femoral neck aBMDs. This em-
phasizes the need for simultaneous preventive actions for car-
diovascular disease and osteoporosis. However, the underly-
ing mechanisms may differ between men and women; there-
fore, this requires investigation.
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